| Tag | Content |
|---|
EnhancerAtlas ID | HS018-21824 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr7:106192260-106194290 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXF2 | MA0030.1 | chr7:106193096-106193110 | TTTGTTTATGTTTA | - | 6.3 | | RUNX3 | MA0684.1 | chr7:106193336-106193346 | TTTGCGGTTT | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_39907 | chr7:106193105-106194751 | K562 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH07I106552 | chr7 | 106192481 | 106193812 | | GH07I106553 | chr7 | 106194042 | 106194286 |
|
Enhancer Sequence | GATCAGCTGC CATGGCATTC ATTCAGTATG GTAGAGAAGA GCACATTGAT TGTTATTGCT 60
ATTGGCTAAA TTTCCTGACA CCTTGTCAGA ATGACAAATG AAGGAAGCAG CAAGTCCTCA 120
CACAACCATG ACTTCTTAGG CAGCATCACC TGGGGTTTCA ACACCAGTAG TTATAGCAGG 180
TAGACCATGA GCTTTGGGCC AAGACATGCC CAGTTCCAAA CCCTAATTTA GACACATCCT 240
AGAACCACAA CAAGGTTTTT CCTTACTTGA AAGACTTTGT CAAAGGCTTG TTCCTGCTAG 300
CTGACTCACT GCTGATACAG GACACGAGGA ACCCCAGACA TCCCACCATT CCTCATTTGG 360
TGTCTGCCCA CTTACACAGA ACCCTGTCTG CCTCTTCTCT TGAGCCAGGC CCAGGTGGTA 420
GGGAGCCACA TTAAGAATGG TGGACAAAGA ATGATAAACT CTCTCAAGCC CATTCCAGGA 480
CAATCCAAGT AATCTAAAGG AGGATTCATA CAGGAAAACA AGTTAATACA ATTAACCAGA 540
ATGAAGGGGT AAACTAGAGA GTTGGAAGGA AAGAGAGGAA AAAAACATAA GCAAAAGCTG 600
AATGGTTGGG TGGTTCAAGG CCTAGATACT TTCATTAGGC CTGGAATTAA GTGGAAAAGC 660
AATTCAGCTG CCTTCTGCAT GAGAGAAAGA GAGAGGAGCC CGCATAAAGG CCATTTATGG 720
TCCAGGACAG AGAGATGAAA GAAAGAGAAT TTTTAGAGCC TGACAGAGAA GTTAGGAGGG 780
AACAGTAGTA AAAAAGAGGG AAATTAGATA AGAAGACATT TTGAAGAAAC ACATAATTTG 840
TTTATGTTTA AATATTTTAT TCTTTGTGTG GTCTCAGTGG AAAATTGCCA AAGGGATGAT 900
GTGTTTTACT TGCTTCACAA AGGGCCTTGC ACAGGGCCCC ATGCACGCTT CCCATCCTTT 960
ATGGCTGACT CCTGCAATAC ATGTCCCCTA AACTCAGAGA ACTCCCTTGA GGATCTCTTG 1020
TGTGGCCATT GCCCACATTG CTCTGGGATA TCATGAGCAT TGTTGCCTTG TACAGCTTTG 1080
CGGTTTACAA GAGAGTCGCT AAACATTTCA CCAAAGTCAT TCTGAAGATC CCCTTTCAAC 1140
AGTTTCATGC AATGGCGATT TTCACTTCTG CAAAACTGCA ATGAAGGCCA CATCATCTTT 1200
TTTCAAGGTC TGTGAGTCAC TTGAGATTAT GGCTGTTATT AATAGACTGC AAAATCAACC 1260
ATCTCCTTCT TCACCTCAGC CAGTCAGTTG AGCATTCAAT ATGTATTGAG AACCTATAAT 1320
GCCTTTGCCT TCAAGAGGCA CAGGTCAGTT CTGTCCTCAA GAAGCTGCCC CCAAGGTGTC 1380
CAGCTATGTT CCTATCTGGA GGGAGGAGAA GGCCATCCTT AATCTTTGGG GCTGATGAGT 1440
CCAGCGCTTC TTCAACATTT CCTGTCTCAT AAACCCCTCC CCTCCCATTA CTTTCTCTGA 1500
AAAAGTAATT TGATATTCTG GGAGAAAGGA GGAGTTTGGA GGGCAGGAGA GGTTTCCCAC 1560
ACCCCCAAAT CATTCCAAGA TGTCACTAAG GGCAGTCCTC TTTAATTCTT CATCTGCTGC 1620
TTTGGGGCAT CTACCATTTG CTCAGTGGCA CCATCTCACA TGAAATCAAA TATCCTCAAA 1680
ATCCATCAAC TGACGTCTTC TGTTGGAAAG GGATAACTTG GGTCTACTTC ATTGGAACCT 1740
TCAAATTTAA GACTCTTGCC TAAGACTGTG GGTTGCTCTT CCATTACCAC ACCAATCAAA 1800
TCAGCTGAAT CTTAGAGAGC AGGGCTCTGA AGGAATAGAG GAGGGGTGAG AACACGCCAG 1860
GGGAGGACAG CAAGAGGTAA AAGATAAGTC TTTGACAGTC AGATCCCTGA GTACTAGGAG 1920
TGGACGTTTG GAGGCTCACT GAAAGGGAGA ATGGAAAGAT AAAAGACACC ATAGAGCCAG 1980
GATGAACTCT GTCTACCACT GCACTTTGAT GAGGTCCTGC TCAGTACATA 2030
|
